Literature DB >> 18548141

The 2008 Canadian Hypertension Education Program recommendations: the scientific summary -- an annual update.

.   

Abstract

The present paper summarizes and highlights key messages of the 2008 Canadian Hypertension Education Program recommendations for the diagnosis and management of hypertension. The 2008 recommendations emphasize proper self-measurement of blood pressure as a step toward greater patient involvement in hypertension management. Home measurement is a better predictor of cardiovascular events than office measures; it can also confirm the diagnosis of hypertension, improve blood pressure control, reduce the need for medications in some patients, screen for white coat and masked hypertension, and improve medication adherence in nonadherent patients. The recommendations continue to emphasize the importance of reducing dietary sodium and implementing other lifestyle changes to prevent and control hypertension. Furthermore, regular assessment of blood pressure at all appropriate visits and identification and management of all cardiovascular risk factures continue to be the cornerstone of the Canadian Hypertension Education Program. Most of the new evidence in 2008 confirmed previous Canadian Hypertension Education Program recommendations. A notable new recommendation is the option to initiate pharmacotherapy with two first therapies if blood pressure is higher than 20/10 mmHg above target. Recently, the Ontario Blood Pressure survey found the treatment and control rate of hypertension in Ontario to be far higher than anywhere else in the world. This speaks to the success of primary care and the Canadian health system in diagnosing, treating and controlling hypertension.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18548141      PMCID: PMC2643188          DOI: 10.1016/s0828-282x(08)70618-4

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  22 in total

1.  The impact of the Canadian Hypertension Education Program on antihypertensive prescribing trends.

Authors:  Norman R C Campbell; Karen Tu; Rollin Brant; Minh Duong-Hua; Finlay A McAlister
Journal:  Hypertension       Date:  2005-12-12       Impact factor: 10.190

2.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

3.  Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg.

Authors: 
Journal:  JAMA       Date:  1970-08-17       Impact factor: 56.272

4.  Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg.

Authors: 
Journal:  JAMA       Date:  1967-12-11       Impact factor: 56.272

5.  The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial.

Authors:  Hans Lithell; Lennart Hansson; Ingmar Skoog; Dag Elmfeldt; Albert Hofman; Bertil Olofsson; Peter Trenkwalder; Alberto Zanchetti
Journal:  J Hypertens       Date:  2003-05       Impact factor: 4.844

6.  Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.

Authors: 
Journal:  Lancet       Date:  2001-09-29       Impact factor: 79.321

7.  Blood pressure control by home monitoring: meta-analysis of randomised trials.

Authors:  Francesco P Cappuccio; Sally M Kerry; Lindsay Forbes; Anna Donald
Journal:  BMJ       Date:  2004-06-11

8.  Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials.

Authors:  M R Law; N J Wald; J K Morris; R E Jordan
Journal:  BMJ       Date:  2003-06-28

Review 9.  Time for chronic disease care and management.

Authors:  Terrence J Montague; Amédé Gogovor; Marilyn Krelenbaum
Journal:  Can J Cardiol       Date:  2007-10       Impact factor: 5.223

Review 10.  The diabetogenic potential of thiazide-type diuretic and beta-blocker combinations in patients with hypertension.

Authors:  James M Mason; Heather O Dickinson; Donald J Nicolson; Fiona Campbell; Gary A Ford; Bryan Williams
Journal:  J Hypertens       Date:  2005-10       Impact factor: 4.844

View more
  6 in total

1.  2009 Canadian Hypertension Education Program recommendations: an annual update.

Authors: 
Journal:  Can Fam Physician       Date:  2009-07       Impact factor: 3.275

2.  Can gestational hypertension be modified by treating nocturnal airflow limitation?

Authors:  John Reid; Regina Taylor-Gjevre; John Gjevre; Robert Skomro; Mark Fenton; Femi Olatunbosun; John R Gordon; David Cotton
Journal:  J Clin Sleep Med       Date:  2013-04-15       Impact factor: 4.062

3.  Pregnant women with gestational hypertension may have a high frequency of sleep disordered breathing.

Authors:  John Reid; Robert Skomro; David Cotton; Heather Ward; Femi Olatunbosun; John Gjevre; Christian Guilleminault
Journal:  Sleep       Date:  2011-08-01       Impact factor: 5.849

4.  Sleep disordered breathing and gestational hypertension: postpartum follow-up study.

Authors:  John Reid; Riley A Glew; Robert Skomro; Mark Fenton; David Cotton; Femi Olatunbosun; John Gjevre; Christian Guilleminault
Journal:  Sleep       Date:  2013-05-01       Impact factor: 5.849

Review 5.  Hypertension in diabetes: a call to action.

Authors:  Norman R C Campbell; Lawrence A Leiter; Pierre Larochelle; Sheldon Tobe; Arun Chockalingam; Richard Ward; Dorothy Morris; Ross Tsuyuki
Journal:  Can J Cardiol       Date:  2009-05       Impact factor: 5.223

6.  Canadian initiatives to prevent hypertension by reducing dietary sodium.

Authors:  Norm R C Campbell; Kevin J Willis; Mary L'Abbe; Robert Strang; Eric Young
Journal:  Nutrients       Date:  2011-08-16       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.